Ataraxis

Ataraxis is revolutionizing oncology by replacing traditional molecular tools with AI precision medicine. Ataraxis develops multi-modal AI foundation models that discover new insights about cancer biology, and uses them to build clinically actionable tools that are faster, more accurate, and widely applicable compared to the standard of care. Ataraxis Breast, the first offering for breast cancer patients, is up to 30% more accurate than the standard of care and expands testing to 100,000 new patients annually.

Areas of Focus

Human Health

Personalized, tech-enabled products for better patient outcomes at lower cost.